secwatch.observer — SEC 8-K summary
======================================

Issuer:     KORU Medical Systems, Inc. (KRMD)
CIK:        0000704440
Form:       8-K
Filed at:   2022-05-18T23:59:59+00:00
Accession:  0001161697-22-000259
Event type: leadership
Sentiment:  neutral
Materiality: 0.65
Item codes: 1.01, 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Repro Med CFO Karen Fisher to resign June 30, 2022; Tom Adams named interim CFO
-------------------------------------------------------------------------------

- CFO Karen Fisher resigns effective June 30, 2022; no disagreements with company.
- Transition Agreement includes severance per existing employment agreement and $60,000 payment.
- Tom Adams, VP of Financial Planning & Analysis since Nov 2021, will serve as interim CFO from July 1.
- Adams has 20+ years med-tech/pharma finance experience, previously at Integra Life Sciences and Pfizer.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/704440/000116169722000259/0001161697-22-000259-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/704440/000116169722000259/form_8-k.htm
  HTML page:      https://secwatch.observer/filing/0001161697-22-000259

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer